LV10312B - The ciliary neurotrophic factor receptor - Google Patents

The ciliary neurotrophic factor receptor Download PDF

Info

Publication number
LV10312B
LV10312B LVP-93-978A LV930978A LV10312B LV 10312 B LV10312 B LV 10312B LV 930978 A LV930978 A LV 930978A LV 10312 B LV10312 B LV 10312B
Authority
LV
Latvia
Prior art keywords
cntfr
cntf
nucleic acid
celis
receptor
Prior art date
Application number
LVP-93-978A
Other languages
English (en)
Latvian (lv)
Other versions
LV10312A (lv
Inventor
Davis Samuel
Stephen P Squinto
Mark E Furth
Yancopoulos George
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/676,647 external-priority patent/US5426177A/en
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of LV10312A publication Critical patent/LV10312A/xx
Publication of LV10312B publication Critical patent/LV10312B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C07K2319/41—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation containing a Myc-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
LVP-93-978A 1990-06-01 1993-06-30 The ciliary neurotrophic factor receptor LV10312B (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US53228590A 1990-06-01 1990-06-01
US07/676,647 US5426177A (en) 1990-06-01 1991-03-28 Ciliary neurotrophic factor receptor
US70067791A 1991-05-15 1991-05-15
PCT/US1991/003896 WO1991019009A1 (en) 1990-06-01 1991-06-03 The ciliary neurotrophic factor receptor

Publications (2)

Publication Number Publication Date
LV10312A LV10312A (lv) 1994-10-20
LV10312B true LV10312B (en) 1995-10-20

Family

ID=27415086

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-93-978A LV10312B (en) 1990-06-01 1993-06-30 The ciliary neurotrophic factor receptor

Country Status (14)

Country Link
EP (1) EP0533846B1 (pt)
JP (1) JP3266611B2 (pt)
AT (1) ATE195341T1 (pt)
AU (1) AU656732B2 (pt)
CA (1) CA2084075C (pt)
DE (1) DE69132361T2 (pt)
FI (1) FI925457A0 (pt)
HU (2) HUT63464A (pt)
IE (1) IE911867A1 (pt)
IL (1) IL98304A (pt)
LV (1) LV10312B (pt)
NO (1) NO924614L (pt)
PT (1) PT97821A (pt)
WO (1) WO1991019009A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5169764A (en) * 1990-08-08 1992-12-08 Regeneron Pharmaceuticals, Inc. Multitrophic and multifunctional chimeric neurotrophic factors, and nucleic acids and plasmids encoding the chimeras
US5360740A (en) * 1992-07-02 1994-11-01 Regeneron Pharmaceuticals, Inc. Assay system for degenerative muscle disease
US6472178B1 (en) 1998-02-27 2002-10-29 Regeneron Pharmaceuticals, Inc. Nucleic acids encoding a modified ciliary neurotrophic factor and method of making thereof
AU6130094A (en) * 1993-01-29 1994-08-15 Regeneron Pharmaceuticals, Inc. Methods of treatment using ciliary neurotrophic factor
DE69410473T2 (de) * 1993-09-09 1998-10-22 Regeneron Pharma Testsystem unter verwendung des cntf-signaltransduktionsweges
DE4331297A1 (de) * 1993-09-15 1995-03-16 Henkel Kgaa Stückseifen
EP1365785A2 (en) * 2000-05-24 2003-12-03 Regeneron Pharmaceuticals, Inc. Use of ciliary neurotrophic factor
US20200297868A1 (en) * 2016-12-14 2020-09-24 University Of Cincinnati Methods and compositions for the treatment of als
CN113607714B (zh) * 2021-10-08 2022-01-11 成都齐碳科技有限公司 分子膜成膜或表征器件、装置、方法以及生物芯片

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5017375A (en) * 1982-11-24 1991-05-21 Baylor College Of Medicine Method to prepare a neurotrophic composition
US4923696A (en) * 1987-05-04 1990-05-08 Baylor College Of Medicine Method to prepare a neurotrophic composition
US4997929A (en) * 1989-01-05 1991-03-05 Synergen, Inc. Purified ciliary neurotrophic factor
US5011914A (en) * 1989-01-05 1991-04-30 Collins Franklin D Purified ciliary neurotrophic factor
IE903130A1 (en) * 1989-09-15 1991-03-27 Regeneron Pharma Ciliary neurotrophic factor
HUT62033A (en) * 1990-03-14 1993-03-29 Fidia Spa Process for producing human ciliary body neuronotropic factor
IT1247150B (it) * 1991-01-21 1994-12-12 Fidia Spa Processo per la sintesi e la purificazione del fattore neuronotroficociliare umano (cntf) da escherichia coli.

Also Published As

Publication number Publication date
FI925457L (fi) 1992-11-30
IL98304A (en) 2008-08-07
JP3266611B2 (ja) 2002-03-18
DE69132361T2 (de) 2001-03-29
EP0533846A4 (pt) 1994-04-27
LV10312A (lv) 1994-10-20
NO924614D0 (no) 1992-11-30
WO1991019009A1 (en) 1991-12-12
AU656732B2 (en) 1995-02-16
EP0533846A1 (en) 1993-03-31
ATE195341T1 (de) 2000-08-15
DE69132361D1 (de) 2000-09-14
HU211976A9 (en) 1996-01-29
CA2084075A1 (en) 1991-12-02
IL98304A0 (en) 1992-06-21
NO924614L (no) 1993-01-21
IE911867A1 (en) 1991-12-04
AU8233791A (en) 1991-12-31
FI925457A7 (fi) 1992-11-30
JPH06507062A (ja) 1994-08-11
CA2084075C (en) 2005-08-16
HUT63464A (en) 1993-08-30
FI925457A0 (fi) 1992-11-30
PT97821A (pt) 1992-02-28
EP0533846B1 (en) 2000-08-09
HU9203772D0 (en) 1993-03-29

Similar Documents

Publication Publication Date Title
US5843749A (en) Ehk and Ror tyrosine kinases
US5814478A (en) Tyrosine kinase receptors and ligands
US5648334A (en) Methods of treatment using ciliary neurotrophic factor
US6413740B1 (en) Tyrosine kinase receptors and ligands
US5426177A (en) Ciliary neurotrophic factor receptor
US20030082672A1 (en) Dna encoding galanin galr2 receptors and uses thereof
EP0533846B1 (en) The ciliary neurotrophic factor receptor
IE83306B1 (en) The ciliary neurotrophic factor receptor
PT100423A (pt) Sistemas de ensaio da actividade da neurotrofina
US5849897A (en) Nucleic acid molecule encoding ciliary neurotrophic factor receptor
US5656473A (en) Human Dmk receptor
WO1996004389A1 (en) Rtk/cytokine receptor chimeras
EP0859840B1 (en) Biologically active eph family ligands
RU2190663C2 (ru) Белок атр-чувствительного калиевого канала и кодирующий его дезоксирибонуклеотид
AU710728B2 (en) Denervated muscle kinase (dmk), a receptor of the tyrosine kinase super family
JP2005505264A (ja) 新規ヒトプロトンゲート調節チャンネル
JP2004201693A (ja) 除神経筋キナーゼ（ｄｍｋ）、チロシンキナーゼスーパーファミリーのレセプター
Harris Regulation of atrial natriuretic factor gene expression during myocardial cell hypertrophy
WO1998036060A1 (fr) Utilisation a des fins de diagnostic et therapeutiques d'un polypeptide a activite de recepteur ob25 exprime par les cellules myelinisantes